13F-HR filed by EcoR1 Capital, LLC
EcoR1 Capital, LLC filed this 13F-HR for the quarter ended 2017-06-30, filed 2017-08-14, with 36 holding rows worth $563,229,000.
- Accession
- 0001140361-17-032004
- Filer
- CIK 1587114
- Filed
- 2017-08-14
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q2 2017
A holdings report, 36 entries on the cover page, a total value of $563,229,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $563,229,000 with VALUE read as thousands by filing date, 13F file number 028-16764. The quarter's positions are built on this report. The resolved quarter.
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| ALEXION PHARMACEUTICALS INC | 015351909 | COM | 569,500 | $78,215,000 | thousands by filing date | call |
| IRONWOOD PHARMACEUTICALS INC | 46333X108 | COMMON STOCK | 3,753,635 | $70,869,000 | thousands by filing date | |
| ASSEMBLY BIOSCIENCES INC | 045396108 | COM | 2,943,164 | $60,776,000 | thousands by filing date | |
| FIBROGEN INC | 31572Q808 | COM | 1,585,457 | $51,210,000 | thousands by filing date | |
| LAKEFRONT BIOTHERAPEUTICS NV | 36315X101 | SPON ADR | 578,505 | $44,267,000 | thousands by filing date | |
| ASCENDIS PHARMA A/S DKK 1.0 AD | 04351P101 | SPONSORED ADR | 1,482,600 | $41,157,000 | thousands by filing date | |
| GILEAD SCIENCES INC | 375558903 | COM | 500,000 | $38,045,000 | thousands by filing date | call |
| SANGAMO THERAPEUTICS INC | 800677106 | COM | 2,568,119 | $22,599,000 | thousands by filing date | |
| KURA ONCOLOGY INC COM | 50127T109 | Stock | 2,033,622 | $18,913,000 | thousands by filing date | |
| TOCAGEN INC | 888846102 | COM | 1,502,373 | $18,074,000 | thousands by filing date | |
| CYTOMX THERAPEUTICS INC | 23284F105 | COMMON STOCK | 794,969 | $12,322,000 | thousands by filing date | |
| EDITAS MEDICINE INC | 28106W103 | COM | 717,107 | $12,033,000 | thousands by filing date | |
| CASCADIAN THERAPEUTICS INC | 14740B606 | COM NEW | 3,000,000 | $11,145,000 | thousands by filing date | |
| CORVUS PHARMACEUTICALS INC | 221015100 | COM | 805,000 | $9,741,000 | thousands by filing date | |
| VERTEX PHARMACEUTICALS INC | 92532F900 | CALL | 60,000 | $9,109,000 | thousands by filing date | call |
| FATE THERAPEUTICS INC | 31189P102 | COM | 2,537,026 | $8,220,000 | thousands by filing date | |
| ATYR PHARMA INC | 002120103 | COM | 2,292,659 | $7,795,000 | thousands by filing date | |
| OVASCIENCE INC | 69014Q101 | COM | 3,512,332 | $5,479,000 | thousands by filing date | |
| ACLARIS THERAPEUTICS INC COM | 00461U105 | Stock | 185,472 | $5,030,000 | thousands by filing date | |
| KINDRED BIOSCIENCES INC COM | 494577109 | Stock | 544,880 | $4,686,000 | thousands by filing date | |
| TETRAPHASE PHARMACEUTICALS INC | 88165N105 | COMMON STOCK | 633,400 | $4,516,000 | thousands by filing date | |
| EDITAS MEDICINE INC | 28106W903 | COM | 255,000 | $4,315,000 | thousands by filing date | call |
| REGULUS THERAPEUTICS INC | 75915K101 | COM | 3,709,144 | $3,656,000 | thousands by filing date | |
| ACHILLION PHARMACEUTICALS IN | 00448Q201 | COM | 742,835 | $3,410,000 | thousands by filing date | |
| NABRIVA THERAPEUTICS PLC | G63637105 | SHS | 264,773 | $2,775,000 | thousands by filing date | |
| DICERNA PHARMACEUTICALS INC | 253031108 | COM | 767,992 | $2,435,000 | thousands by filing date | |
| Adverum Biotechnologies, Inc. | 00773U108 | Common Stock | 874,447 | $2,186,000 | thousands by filing date | |
| MINERVA NEUROSCIENCES INC COM NEW | 603380106 | Stock | 223,802 | $1,981,000 | thousands by filing date | |
| BIOHAVEN PHARMACEUTICAL HOLDIN | G11196105 | COM | 70,000 | $1,750,000 | thousands by filing date | |
| AGIOS PHARMACEUTICALS INC | 00847X104 | COM | 23,300 | $1,199,000 | thousands by filing date | |
| CHEMOCENTRYX INC | 16383L106 | COM | 118,000 | $1,104,000 | thousands by filing date | |
| Bristol-Myers Squibb Company | 110122108 | COM | 17,060 | $951,000 | thousands by filing date | |
| CLOVIS ONCOLOGY INC | 189464100 | COM | 10,000 | $936,000 | thousands by filing date | |
| ALNYLAM PHARMACEUTICALS INC COM | 02043Q107 | Stock | 10,425 | $831,000 | thousands by filing date | |
| SEATTLE GENETICS INC | 812578102 | COM | 15,000 | $776,000 | thousands by filing date | |
| ARATANA THERAPEUTICS INC | 03874P101 | COM | 100,000 | $723,000 | thousands by filing date |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0001140361-17-032004 | this filing | 2017-08-14 | acceptance time not in the bulk data set |